NO metabolites, NO synthase inhibitors, thiols, and N-acetyl-β-glucosaminidase (NAGase) are biomarkers suitable for the detection of endothelial dysfunction and oxidative stress during the early stages of impaired response to insulin [6]. The gene discussed is INS; the disease is endothelial dysfunction.